Frequency and clinical significance of localized adverse events following mass drug administration for lymphatic filariasis in an endemic area in South India

Authors

Vijesh Sreedhar Kuttiatt, ICMR-Vector Control Research Centre
Roopali K Somani, ICMR-Vector Control Research Centre
Subramanian Swaminathan, ICMR-Vector Control Research Centre
Kaliannagounder Krishnamoorthy, ICMR-Vector Control Research Centre
Gary J Weil, Washington University School of Medicine in St. Louis
Jambulingam Purushothaman, ICMR-Vector Control Research Centre

Journal

The American Journal of Tropical Medicine and Hygiene

Publication Date

2020

Volume

102

Issue

1

First Page

96

Last Page

99

Document Type

Open Access Publication

DOI

10.4269/ajtmh.19-0532

Rights and Permissions

Vijesh Sreedhar Kuttiatt, Roopali K. Somani, Subramanian Swaminathan, Kaliannagounder Krishnamoorthy, Gary J. Weil, and Jambulingam Purushothaman. Frequency and Clinical Significance of Localized Adverse Events following Mass Drug Administration for Lymphatic Filariasis in an Endemic Area in South India. Am. J. Trop. Med. Hyg., 102(1), 2020, pp. 96–99. doi:10.4269/ajtmh.19-0532

Recommended Citation

Kuttiatt, Vijesh Sreedhar; Somani, Roopali K; Swaminathan, Subramanian; Krishnamoorthy, Kaliannagounder; Weil, Gary J; and Purushothaman, Jambulingam, "Frequency and clinical significance of localized adverse events following mass drug administration for lymphatic filariasis in an endemic area in South India." The American Journal of Tropical Medicine and Hygiene. 102, 1. 96 - 99. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/8730